Scholars Central

Conference abstractPublished 30 May 2019

Synthesis of new analogs of diaminopimelic acid and lysine

Authors: Miyanou Rosales-Hurtado

University of Nimes, France

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Infections caused by multidrugresistant bacteria represent one of the biggest challenges in the medical field. There is an urgent need to develop new antibacterial targets and antibacterial agents to combat multidrug-resistance bacteria. For several years, the main target has been focused on the peptidoglycan biosynthesis pathway which provides a potential route to design novel antibiotic compounds. In fact, most bacteria require either lysine or its biosynthetic precursor, diaminopimelate acid (DAP), as a component of the peptidoglycan layer of the cell wall. Nevertheless, DAP/lysine are not present in mammals, thus, inhibitors of this pathway could provide potential antibacterial agents displaying low mammalian toxicity. In order to fight antibacterial resistance, our work focused on the design and synthesis of new analogs of diaminopimelic acid (DAP) and lysine.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • BylineArticles whose byline prints “Miyanou Rosales-Hurtado”